Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kaempferol + zinc is a combination or chelated complex consisting of the natural flavonol kaempferol and the essential trace element zinc. Kaempferol is a dietary flavonoid found in various plants, such as kale, tea, and broccoli, and is recognized for its antioxidant, anti-inflammatory, and potential antineoplastic properties. Zinc is a vital mineral that serves as a structural or catalytic cofactor for over 300 enzymes and is essential for immune function, DNA repair, and cellular metabolism. Research into the kaempferol-zinc complex suggests that the chelation of zinc by the flavonoid can enhance the biological efficacy and stability of both components. This combination is primarily investigated in preclinical studies for its synergistic effects in promoting bone health (osteogenesis), where it stimulates osteoblast differentiation and inhibits bone resorption, making it a candidate for the management of osteoporosis. Additionally, it has been studied for its ability to induce apoptosis in cancer cells and for its potential insulin-mimetic effects in diabetes research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on kaempferol + zinc.